Item - 2022.CC39.13

Tracking Status

  • City Council adopted this item on February 2, 2022 without amendments and without debate.

CC39.13 - Litigation in the United States and Canada Regarding Prescription Opioids

Decision Type:
ACTION
Status:
Adopted
Wards:
All

City Council Decision

City Council on February 2 and 3, 2022, adopted the following:

 

1. City Council adopt the confidential instructions to staff in Confidential Attachment 1 to the report (January 26, 2022) from the City Solicitor.

 

2. City Council authorize the public release of the confidential instructions to staff in Confidential Attachment 1 to the report (January 26, 2022) from the City Solicitor, at the discretion of the City Solicitor.

 

3.  City Council direct that the balance of Confidential Attachment 1 to the report (January 26, 2022) from the City Solicitor remain confidential as it contains advice that is subject to solicitor-client and litigation privilege.

 

Confidential Attachment 1 to the report (January 26, 2022) from the City Solicitor remains confidential at this time in accordance with the provisions of the City of Toronto Act, 2006, as it contains advice that is subject to solicitor-client and litigation privilege. The confidential  instructions to staff in Confidential Attachment 1 to the report (January 26, 2022) from the City Solicitor will be made public at the discretion of the City Solicitor.

Confidential Attachment - Litigation that affects the City of Toronto ('the City") and advice that is subject to solicitor-client privilege.

Background Information (City Council)

(January 26, 2022) Report from the City Solicitor on Litigation In US and Canada Regarding Prescription Opioids (CC 39.13)
https://www.toronto.ca/legdocs/mmis/2022/cc/bgrd/backgroundfile-175673.pdf
Confidential Attachment 1
Source: Toronto City Clerk at www.toronto.ca/council